We are proud to announce that Kinetic River has received our first Japanese patent allowance: Patent No. 6,941,053 “Particle analysis and sorting apparatus and methods.” It was a lengthy process, but well worth it as Japan represents an important segment of the global flow cytometry marketplace.
This marks our company’s fourteenth patent overall (twelve in the U.S., one in China, and now one in Japan), and it further broadens our patent portfolio as the first patent outside the U.S. for our Arno compensation-free flow cytometry platform. Our latest patent extends the reach of our IP coverage in fluorescence lifetime technologies.
For reference, our patents fit into the following families of intellectual property:
- Technologies using fluorescence lifetime, including the Arno (compensation-free flow cytometry), Danube (direct fluorescence lifetime measurements) instruments, Colorado (automated autofluorescence removal), and Tiber (label-free cancer cell detection).
- Extremely high-throughput flow cytometry (Loire).
- Label-free flow cytometry (Yangtze).
- Modular, customizable systems (Potomac).
We are pleased to continue our progress this year, with Japan Patent No. 6,941,053 as our fourth issuance this year.
Learn about our other patents issued in 2021:
- U.S. Patent No. 10,955,330, “Particle Analysis and Sorting Apparatus and Methods.”
- U.S. Patent No. 11,035,778, “Flow Cytometry Apparatus and Methods.”
- U.S. Patent No. 11,060,975, “Methods and Apparatuses for Label-Free Particle Analysis.”
Another congratulations is in order for Kinetic River’s Founder and President, Dr. Giacomo Vacca, who now holds 63 patents (with more on the way). See his full list of patents in his bio.